OrthoPediatrics Corp
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-39.6M | $-37.8M | $-21.0M | $1.3M | $-16.3M | $-32.9M | $-13.7M | $-12.0M |
| Depreciation & Amortization | $21.1M | $19.1M | $17.4M | $13.1M | $10.7M | $8.0M | $4.7M | $2.9M |
| Depreciation | $12.0M | $10.9M | $10.2M | $7.1M | $6.1M | $4.7M | $3.7M | $2.5M |
| Amortization | $8.2M | $7.8M | $7.1M | $6.0M | $4.5M | $3.2M | $887.0K | $378.0K |
| Stock-Based Compensation | $17.8M | $13.5M | $10.5M | $6.7M | $5.8M | $6.2M | $2.6M | $3.2M |
| Net Cash from Operating Activities | $-4.9M | $-27.0M | $-27.0M | $-21.8M | $-13.1M | $-18.5M | $-17.8M | $-15.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $11.1M | $14.3M | $16.9M | $10.0M | $8.1M | $10.5M | $11.8M | $5.3M |
| Business Acquisitions | $0 | $20.2M | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing Activities | $-43.6M | $-13.2M | $41.7M | $-113.4M | $-7.4M | $-69.7M | $-61.9M | $-6.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | $0 | $0 |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $24.0M | $53.1M | $7.3M | $136.0M | $6.0K | $46.7M | $91.0M | $39.7M |
| Net Change in Cash | $-24.2M | $12.8M | $22.6M | $1.5M | $-21.1M | $-41.9M | $11.3M | $18.1M |
| Free Cash Flow | $-16.0M | $-41.3M | $-43.9M | $-31.8M | $-21.2M | $-29.0M | $-29.6M | $-20.8M |